Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
about
Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidineIdentification and Mechanistic Investigation of Drug-Drug Interactions Associated With Myopathy: A Translational Approach.A Case Report of Clonazepam Dependence: Utilization of Therapeutic Drug Monitoring During Withdrawal Period.The Black Book of Psychotropic Dosing and Monitoring.
P2860
Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
@en
type
label
Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
@en
prefLabel
Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
@en
P2093
P1476
Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications
@en
P2093
Greenblatt DJ
Harmatz JS
von Moltke LL
P304
4-11; discussion 12-4
P478
P577
1993-10-01T00:00:00Z